METASTATIC NASOPHARYNGEAL CARCINOMA
Clinical trials for METASTATIC NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo aims to stall return of rare throat cancer
Disease control Recruiting nowThis study is for people with a type of throat cancer (nasopharyngeal carcinoma) that has come back or spread. After initial chemotherapy and immunotherapy, participants receive either the standard immunotherapy (nivolumab) alone or combined with another drug (relatlimab) to see …
Matched conditions: METASTATIC NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
Triple therapy offers new hope for hard-to-treat nose and throat cancer
Disease control Recruiting nowThis study tests whether combining an EGFR antibody, a PD-1 inhibitor, and chemotherapy can help people with nasopharyngeal carcinoma that has come back or spread. About 148 adults aged 18-75 who have not had prior treatment for their advanced cancer will receive this triple ther…
Matched conditions: METASTATIC NASOPHARYNGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for Tough-to-Treat throat cancer: drug cocktail shows promise
Disease control Recruiting nowThis study tests whether adding a targeted drug (cabozantinib) to a two-drug immunotherapy (nivolumab and ipilimumab) can help shrink or stabilize advanced nasopharyngeal cancer that has returned or spread. About 50 adults whose cancer progressed after platinum chemotherapy and i…
Matched conditions: METASTATIC NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC